Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Incyte Corporation
Scientific Title
A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor in Relapsed or Refractory Follicular Lymphoma